Cleveland-Cliffs Option Alert: Jan 16 $25 Puts at the Ask: 299 vs 42 OI

Cleveland-Cliffs Option Alert: Jan 16 $25 Puts at the Ask: 299 @ $17.6 vs 42 OI; Ref=$7.39

Cleveland-Cliffs (NYSE:CLF) Stock

CLEVELAND-CLIFFS INC

Cleveland-Cliffs

Cleveland-Cliffs Inc is a flat-rolled steel producer and manufacturer of iron ore pellets in North America. It is organized into four operating segments based on differentiated products, Steelmaking, Tubular, Tooling and Stamping and European Operations, but operates through one reportable segment -Steelmaking. It is vertically integrated from mined raw materials, direct reduced iron, and ferrous scrap to primary steelmaking and downstream finishing, stamping, tooling and tubing. It serves a diverse range of other markets due to its comprehensive offering of flat-rolled steel products. Geographically, it operates in the United States, Canada and other countries. The majority of revenue is from the United States. It is a supplier of steel to the automotive industry in North America.

Cleveland-Cliffs Inc

Clearfield Inc

CLIFFORD MDERN IVING HLD by CLIFFORD MODERN LIVING HLDGS LTD.

Detroit&#8217;s automakers are hitting speed bumps &#8211; and they're made of steel. Ford Motor Co (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/F#NYSE">F</a>) and General Motors Co (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/GM#NYSE">GM</a>) tumbled 3.7% and 4.1% respectively on the day the U.S. announced <a href="https://www.benzinga.com/news/topics/25/05/45708977/trump-doubles-steel-tariffs-to-50-saying-it-will-secure-american-jobs-backs-us-steels-takeover-by-japans-nippon">50% tariffs on imported steel</a> and aluminum. 
The market didn't wait for earnings calls &#8211; investors immediately priced in the hit to margins.
<h2 class="wp-block-heading">Steel Tariffs Could Add $200-$400 To Per Vehicle Cost</h2>
Tracy Shuchart of NinjaTrader says these fears are justified. &#8220;Steel and aluminum represent 15–20% of total vehicle production costs,&#8221; she said in exclusive insights shared with Benzinga over an email interview. &#8220;For a typical mid-size sedan, we&#8217;re looking at roughly $800–$1,200 in steel content per vehicle. A 50% tariff could easily add $200–400 to vehicle production costs.&#8221;
Read Also: <a href="https://www.benzinga.com/markets/tech/25/06/45786145/trumps-50-steel-tariff-could-drive-up-the-costs-for-automakers-almost-2000-of-cost-for-each-car">Trump&#8217;s 50% Steel Tariff Could Drive Up The Costs For Automakers: &#8216;Almost $2,000 Of Cost For Each Car&#8217;</a>
<h2 class="wp-block-heading">Why Ford, GM Investors Should Brace For Impact?</h2>
Ford and GM are particularly vulnerable because of their long-term supply agreements with Canadian steelmakers, who now face full tariffs. While domestic producers celebrate, automakers will need to renegotiate contracts, seek alternative supply chains, or pass costs onto consumers &#8211; a tough sell in an already competitive EV market.
&#8220;Ford and GM are particularly vulnerable because they source significant steel volumes from Canada under existing supply agreements that will now face the full tariff impact,&#8221; Shuchart said.
Investors who believe these pressures may persist might consider short-term hedges or adding exposure to raw material producers like Cleveland-Cliffs Inc. (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/CLF#NYSE">CLF</a>) and Steel Dynamics Inc. (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/STLD#NASDAQ">STLD</a>) instead.
For ETF-watchers, the Global X U.S. Infrastructure Development ETF (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/PAVE#NYSE">PAVE</a>) offers a blend of industrials and materials exposure that may benefit from rising domestic steel prices.
With tariff-driven cost inflation now a reality, automakers will need to prove they can protect margins without stalling innovation. Until then, the road ahead looks steep.
Read Next: 
<ul class="wp-block-list">
<li><a href="https://www.benzinga.com/markets/commodities/25/06/45766967/us-aluminum-tariffs-risk-supply-chain-and-food-security-industry-insiders-warn">US Aluminum Tariffs Risk Supply Chain And Food Security, Industry Insiders Warn</a></li>
</ul>
Image created using artificial intelligence via Midjourney.

Government

Regulations

Sector ETFs

Commodities

Exclusives

Markets

Interview

ETFs

PAVE

STLD

EXCLUSIVE: Ford, GM Just Hit A Tariff Wall - Will Margins Crumple On Cost Pressures?

Steel tariffs are back with a bang, and investors are already positioning for the winners. As the U.S. slaps a <a href="https://www.benzinga.com/news/topics/25/05/45708977/trump-doubles-steel-tariffs-to-50-saying-it-will-secure-american-jobs-backs-us-steels-takeover-by-japans-nippon" target="_blank" rel="noreferrer noopener">prohibitive 50% tariff</a> on imported steel and aluminum, Cleveland-Cliffs Inc (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/CLF#NYSE">CLF</a>), Nucor Corp (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/NUE#NYSE">NUE</a>) and Steel Dynamics Inc (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/STLD#NASDAQ">STLD</a>) are emerging as the early champions of this protectionist pivot.
According to Tracy Shuchart, senior economist at NinjaTrader, the tariff surge is a short-term policy maneuver, but it brings long-term opportunities for domestic producers. &#8220;At 50%, these tariffs are reaching what economists call prohibitive levels—they&#8217;re so high that they fundamentally distort market mechanisms rather than simply providing competitive protection,&#8221; Shuchart said in an exclusive email interview with Benzinga.
Read Also: <a href="https://www.benzinga.com/markets/tech/25/06/45786145/trumps-50-steel-tariff-could-drive-up-the-costs-for-automakers-almost-2000-of-cost-for-each-car">Trump&#8217;s 50% Steel Tariff Could Drive Up The Costs For Automakers: &#8216;Almost $2,000 Of Cost For Each Car&#8217;</a>
<h2 class="wp-block-heading">Tariffs To Benefit Cleveland, Nucor, Steel Dynamics&#8217; Margins</h2>
Cleveland-Cliffs saw a 25.2% gain in early trading after the announcement, not just on sentiment but solid fundamentals. The company is heavily exposed to imports, particularly in flat-rolled products, and now has room to raise prices by $200-300 per ton while still staying competitive. 
&#8220;Cliffs can immediately implement price increases of $200–300 per ton while still remaining competitive,&#8221; Shuchart added.
Nucor, with its low-cost electric arc furnace model, is positioned to expand its already solid margins. Its scale, cost discipline, and flexible mini-mill network could boost EBITDA margins to the 18–20% range over the next 12–18 months. &#8220;With import competition effectively removed, Nucor can maintain its cost advantage while capturing significantly higher margins,&#8221; Shuchart said.
Meanwhile, Steel Dynamics, which had ventured into aluminum production, now looks prophetic. With both steel and aluminum tariffs rising, Steel Dynamics&#8217;s dual exposure could unlock a new wave of pricing power. &#8220;This diversification strategy, which seemed risky 18 months ago, now looks prescient,&#8221; said Shuchart.
<h2 class="wp-block-heading">Broad-Market Beneficiaries</h2>
Investors looking to ride the broader wave may also consider steel-focused ETFs like the VanEck Steel ETF (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/SLX#NYSE">SLX</a>) or the SPDR S&amp;P Metals and Mining ETF (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/XME#NYSE">XME</a>), which offer diversified exposure to these names.
While these gains are real, Shuchart cautions this is not a forever story. Structural supply gaps and midterm politics could force a policy rethink by late 2025. 
But for now, domestic steel stocks stand to gain, and this trio is leading the charge.
Read Next: 
<ul class="wp-block-list">
<li><a href="https://www.benzinga.com/markets/commodities/25/06/45766967/us-aluminum-tariffs-risk-supply-chain-and-food-security-industry-insiders-warn">US Aluminum Tariffs Risk Supply Chain And Food Security, Industry Insiders Warn</a></li>
</ul>
Photo: Shutterstock

Long Ideas

Trading Ideas

EXCLUSIVE: Tariff Titans - Why Cleveland-Cliffs, Nucor, Steel Dynamics Could Outmuscle The Competition

U.S. stocks were mixed, with the Dow Jones index falling around 200 points on Monday.
Shares of Vera Therapeutics, Inc. (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/VERA#NASDAQ">VERA</a>) rose sharply during Monday's session after the company <a href="https://www.benzinga.com/news/health-care/25/06/45720783/kidney-health-focused-vera-therapeutics-stock-price-spikes-on-heels-of-successful-trial-data">released ORIGIN Phase 3 trial data.</a>
Participants treated with atacicept for immunoglobulin A nephropathy (IgAN) achieved a 46% reduction from baseline in proteinuria as measured by 24-hour urine protein-to-creatinine ratio (UPCR), with a statistically significant and clinically meaningful 42% reduction in UPCR compared to placebo (p&lt;0.0001) at week 36.
Vera Therapeutics shares jumped 56.6% to $29.67 on Monday.
Here are some other big stocks recording gains in today&#8217;s session.
<ul class="wp-block-list">
<li>Applied Digital Corporation (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/APLD#NASDAQ">APLD</a>) surged 44.8% to $9.89 after the company announced a 250MW AI data center lease with CoreWeave.</li>
<li>Kymera Therapeutics, Inc. (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/KYMR#NASDAQ">KYMR</a>) climbed 33.3% to $39.53 after the company announced clinical data for its Phase 1 Healthy volunteer study of KT-621.</li>
<li>Blueprint Medicines Corporation (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/BPMC#NASDAQ">BPMC</a>) gained 26.2% to $127.93 after the company announced that Sanofi will acquire them for $9.5 billion.</li>
<li>Cleveland-Cliffs Inc. (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/CLF#NYSE">CLF</a>) gained 23.2% to $7.18 after Trump said he would double their tariffs to 50%.</li>
<li>Century Aluminum Company (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/CENX#NASDAQ">CENX</a>) rose 22% to $18.89 after Trump said he would double their tariffs to 50%.</li>
<li>Liquidia Corporation (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/LQDA#NASDAQ">LQDA</a>) gained 18.2% to $17.64 after the company announced it began shipping its newly FDA-approved Yutrepia. Additionally, Needham raised its price target on the stock from $25 to $32.</li>
<li>REGENXBIO Inc. (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/RGNX#NASDAQ">RGNX</a>) jumped 16.4% to $10.30.</li>
<li>Tempus AI, Inc. (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/TEM#NASDAQ">TEM</a>) gained 14.1% to $62.95 after the company introduced its fuses program for precision-based medicine and xM for advanced cancer treatment response monitoring.</li>
<li>First Majestic Silver Corp. (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/AG#NYSE">AG</a>) rose 10.6% to $6.83.</li>
<li>Steel Dynamics, Inc. (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/STLD#NASDAQ">STLD</a>) surged 10.5% to $135.93. Shares of steel and aluminum stocks traded higher after Trump said he would double their tariffs to 50%.</li>
<li>Hecla Mining Company (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/HL#NYSE">HL</a>) gained 10.4% to $5.67.</li>
<li>Nucor Corporation (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/NUE#NYSE">NUE</a>) gained 10% to $120.20. BMO Capital analyst Katja Jancic upgraded Nucor from Market Perform to Outperform and raised the price target from $140 to $145.</li>
<li>ImmunityBio, Inc. (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/IBRX#NASDAQ">IBRX</a>) rose 6.2% to $2.8250. ImmunityBio received FDA expanded access authorization for the treatment of Lymphopenia with ANKTIVA in patients with solid tumors</li>
<li>Eldorado Gold Corporation (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/EGO#NYSE">EGO</a>) rose 6.1% to $21.32.</li>
</ul>
Now Read This: 
<ul class="wp-block-list">
<li><a href="https://www.benzinga.com/cannabis/25/06/45719355/top-3-utilities-stocks-that-may-crash-in-june">Top 3 Utilities Stocks That May Crash In June</a> </li>
</ul>
Photo via Shutterstock

APLD

BPMC

CENX

IBRX

KYMR

LQDA

RGNX

VERA

Vera Therapeutics, Applied Digital, Kymera Therapeutics And Other Big Stocks Moving Higher On Monday

Cleveland-Cliffs Inc (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/CLF#NYSE">CLF</a>) shares are soaring Monday after U.S. President Donald Trump announced plans to double <a href="https://www.benzinga.com/news/topics/25/05/45708977/trump-doubles-steel-tariffs-to-50-saying-it-will-secure-american-jobs-backs-us-steels-takeover-by-japans-nippon">tariffs on steel</a>.
What Happened: Trump <a href="https://truthsocial.com/@realDonaldTrump/posts/114599330494282325">announced</a> on Friday that he would increase steel tariffs from 25% to 50% in an effort to protect the U.S. steel industry. 
&#8220;Our steel and aluminum industries are coming back like never before. This will be yet another BIG jolt of great news for our wonderful steel and aluminum workers,&#8221; Trump said in a post on Truth Social.
The move has added to global trade tensions. The European Commission said over the weekend that Europe was prepared to retaliate against the tariff hike, per Reuters. 
Trump said the 25% tariff increases on steel and aluminum would take effect on Wednesday. Cleveland-Cliffs shares were up more than 25% on the news. Shares of Steel Dynamics and Nucor were also up about 11% each at last check, according to <a href="http://pro.benzinga.com">Benzinga Pro</a>. The VanEck Steel ETF (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/SLX#NYSE">SLX</a>) was up 3.10% at the time of publication.
Check This Out: <a href="https://www.benzinga.com/trading-ideas/movers/25/06/45712354/united-states-steel-applovin-and-ulta-beauty-are-among-top-large-cap-gainers-last-week-may-26-may-30-are-the-others-in-your-portfolio">United States Steel, Applovin And Ulta Beauty Are Among Top Large-Cap Gainers Last Week (May 26-May 30): Are The Others In Your Portfolio?</a>
<h3 class="wp-block-heading">Is CLF A Good Stock To Buy?</h3>
Wall Street analysts view Cleveland-Cliffs on the whole as a Buy, given the history of coverage over the past three months. Christopher LeFemina from Jefferies in Cleveland-Cliffs is the most bearish, expecting a 40.0% fall in the stock in the coming year.
But looking at how the market as a whole thinks of the stock, you can reference historical price action for views on whether investors feel strongly about the stock one way or another. In the past three months, Cleveland-Cliffs fell 23.15%, which indicates that opinion soured on the business and how attractive it is to own based on either its stock price, or underlying fundamentals, like revenue, which fell 10.96% over the past year.
A complete overview of how Wall Street views individual stocks is available <a href="https://www.benzinga.com/analyst-stock-ratings">here</a>, while real time updates on the latest analyst actions will be delivered via <a href="https://pro.benzinga.com">Benzinga PRO</a>. Try it for free.
CLF Price Action: <a href="http://benzinga.com/quote/clf">Cleveland-Cliffs shares</a> were up 27.7% at $7.44 at the time of publication Monday, according to <a href="http://pro.benzinga.com">Benzinga Pro</a>.
Photo: <a href="https://www.shutterstock.com/g/JHVEPhoto">JHVEPhoto</a>/Shutterstock.

News

Movers

Cleveland-Cliffs Stock Is Ripping Higher Monday: Here's Why

WIIM

Shares of steel and aluminum stocks are trading higher after Trump said he would double their tariffs to 50%.

<ul>
<li>TSLA</li>
<li>GLD</li>
<li>UNH</li>
<li>NVDA</li>
<li>GOOGL</li>
<li>GOOG</li>
<li>CLF</li>
<li>PLTR</li>
<li>BULL</li>
<li>RDDT</li>
</ul>
Data from <a href="https://swaggystocks.com/dashboard/wallstreetbets/ticker-sentiment">https://swaggystocks.com/dashboard/wallstreetbets/ticker-sentiment</a>
&nbsp;

BULL

GOOG

GOOGL

NVDA

PLTR

RDDT

TSLA

Top 10 Trending Stocks On WallStreetBets As Of June 2, 2025 (Via Swaggy Stocks)

<h3>Gainers</h3>
<ul>
<li>Cleveland-Cliffs (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/CLF#NYSE">CLF</a>) shares increased by 26.1% to $7.35 during Monday's pre-market session. The market value of their outstanding shares is at $3.6 billion. </li>
<li>Century Aluminum (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/CENX#NASDAQ">CENX</a>) shares rose 18.85% to $18.41. The market value of their outstanding shares is at $1.7 billion. </li>
<li>Steel Dynamics (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/STLD#NASDAQ">STLD</a>) stock moved upwards by 11.31% to $137.0. The market value of their outstanding shares is at $20.3 billion. </li>
<li>Nucor (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/NUE#NYSE">NUE</a>) stock moved upwards by 10.74% to $121.11. The company's market cap stands at $27.9 billion. </li>
<li>Origin Materials (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/ORGN#NASDAQ">ORGN</a>) stock moved upwards by 9.25% to $0.48. The company's market cap stands at $71.6 million. </li>
<li>Commercial Metals (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/CMC#NYSE">CMC</a>) shares moved upwards by 9.2% to $50.88. The market value of their outstanding shares is at $5.7 billion. </li>
</ul>
<h3>Losers</h3>
<ul>
<li>Bolt Projects Holdings (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/BSLK#NASDAQ">BSLK</a>) shares declined by 8.3% to $3.1 during Monday's pre-market session. The company's market cap stands at $6.3 million. </li>
<li>IT Tech Packaging (AMEX:<a class="ticker" href="https://www.benzinga.com/stock/ITP#AMEX">ITP</a>) shares decreased by 6.85% to $0.18. The market value of their outstanding shares is at $3.0 million. </li>
<li>IperionX (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/IPX#NASDAQ">IPX</a>) stock decreased by 6.5% to $22.62. The market value of their outstanding shares is at $662.0 million. </li>
<li>Millennium Group Intl (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/MGIH#NASDAQ">MGIH</a>) stock fell 6.05% to $1.4. The company's market cap stands at $15.7 million. </li>
<li>Tantech Hldgs (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/TANH#NASDAQ">TANH</a>) stock declined by 5.41% to $2.1. The company's market cap stands at $2.8 million. 
See Also: <a href="http://www.benzinga.com/money/best-basic-materials-stocks/" title="www.benzinga.com/money/best-basic-materials-stocks/">www.benzinga.com/money/best-basic-materials-stocks/</a></li>
</ul>
This article was generated by Benzinga's automated content engine and reviewed by an editor.

BSLK

MGIH

ORGN

TANH

11 Materials Stocks Moving In Monday's Pre-Market Session

LYRA: 319% &#x7C; <a href="https://www.benzinga.com//node/45717857">Lyra Therapeutics' ENLIGHTEN 2 Phase 3 Trial Of LYR-210 For Chronic Rhinosinusitis Met Its Primary Endpoint, With LYR-210 Demonstrating Statistically Significant Improvement Compared To Sham Control In A Composite Of The Three Cardinal Symptoms</a>
&nbsp;
CLF: 36% &#x7C; <a href="https://www.benzinga.com//node/45706950">President Donald Trump Says He Would Be Increasing Tariffs On Steel To 50% From 25%; Tariffs To Go Into Effect Next Week</a>
&nbsp;
&nbsp;

LYRA

Market-Moving News for June 2nd

Shares of Blueprint Medicines Corporation (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/BPMC#NASDAQ">BPMC</a>) rose sharply in <a href="https://www.benzinga.com/quote/BPMC/news">today's pre-market trading</a>.
Sanofi SA (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/SNY#NASDAQ">SNY</a>) announced plans to acquire Blueprint Medicines for $9.5 billion.
Blueprint Medicines shares jumped 26.9% to $128.62 in the pre-market trading session.
Here are some other stocks moving in pre-market trading.
<h3 class="wp-block-heading">Gainers</h3>
<ul class="wp-block-list">
<li>Lyra Therapeutics, Inc. (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/LYRA#NASDAQ">LYRA</a>) shares jumped 199% to $14.74 in pre-market trading after the company reported positive results from the ENLIGHTEN 2 Phase 3 trial of LYR-210 achieving statistically significant results for primary and key secondary endpoints in the treatment of Chronic Rhinosinusitis (CRS).</li>
<li>InMed Pharmaceuticals Inc. (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/INM#NASDAQ">INM</a>) rose 93.2% to $4.81 in pre-market trading.</li>
<li>Vera Therapeutics, Inc. (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/VERA#NASDAQ">VERA</a>) surged 69% to $32.02 in pre-market trading after the company said Atacicept ORIGIN Phase 3 trial met primary endpoint of reduction in UPCR for IgAN treatment.</li>
<li>Brand Engagement Network, Inc. (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/BNAI#NASDAQ">BNAI</a>) jumped 68.5% to $0.47 in pre-market trading after gaining 13% on Friday.</li>
<li>Basel Medical Group Ltd (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/BMGL#NASDAQ">BMGL</a>) surged 51.4% to $9.20 in pre-market trading after jumping 485% on Friday.</li>
<li>Black Spade Acquisition II Co (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/BSII#NASDAQ">BSII</a>) gained 37.3% to $13.29 in pre-market trading after falling 5% on Friday.</li>
<li>DigiAsia Corp. (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/FAAS#NASDAQ">FAAS</a>) climbed 27.7% to $1.6990 in pre-market trading after jumping 24% on Friday.</li>
<li>Cleveland-Cliffs Inc. (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/CLF#NYSE">CLF</a>) rose 25.6% to $7.32 in pre-market trading.</li>
<li>BioNTech SE (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/BNTX#NASDAQ">BNTX</a>) gained 14.1% to $109.32 in pre-market trading. BioNTech and Bristol Myers Squibb announced a global strategic partnership to co-develop and co-commercialize next-generation bispecific antibody candidate BNT327 broadly for multiple solid tumor types</li>
</ul>
<h3 class="wp-block-heading">Losers</h3>
<ul class="wp-block-list">
<li>ReShape Lifesciences Inc. (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/RSLS#NASDAQ">RSLS</a>) shares dipped 23.2% to $3.77 in pre-market trading. ReShape Lifesciences entered into equity distribution agreement relating to sale of up to $9.7 million of shares of common stock.</li>
<li>China Liberal Education Holdings Limited (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/CLEU#NASDAQ">CLEU</a>) shares fell 22.6% to $0.7500 in pre-market trading after the company announced suspension of Nasdaq trading.</li>
<li>Silexion Therapeutics Corp (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/SLXN#NASDAQ">SLXN</a>) fell 20.2% to $0.8300 in pre-market trading after gaining 8% on Friday.</li>
<li>SharpLink Gaming, Inc. (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/SBET#NASDAQ">SBET</a>) declined 18.4% to $62.60 in pre-market trading after the company filed for mixed shelf offering.</li>
<li>ContextLogic Inc. (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/LOGC#NASDAQ">LOGC</a>) shares tumbled 18.3% to $6.70 in pre-market trading. ContextLogic will commence trading on the OTC Markets and delist from the Nasdaq.</li>
<li>Xilio Therapeutics, Inc. (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/XLO#NASDAQ">XLO</a>) fell 17.9% to $0.8788 in pre-market trading after the company announced a proposed public offering.</li>
<li>Super League Enterprise, Inc. (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/SLE#NASDAQ">SLE</a>) fell 16.4% to $0.1629 in today's pre-market trading. Super League Enterprise, on Friday, announced a registered direct offering.</li>
<li>Tian Ruixiang Holdings Ltd (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/TIRX#NASDAQ">TIRX</a>) dipped 16% to $1.68 in pre-market trading. TIAN RUIXIANG shares gained 8% on Friday after the company announced plans to buy Ucare for $150 million in an all-stock deal.</li>
<li>Lucid Diagnostics Inc. (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/LUCD#NASDAQ">LUCD</a>) shares fell 15.1% to $1.18 in pre-market trading. Lucid Diagnostics may offer sell shares of common stock of up to $25 MILLION.</li>
<li>Algoma Steel Group Inc. (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/ASTL#NASDAQ">ASTL</a>) fell 9.2% to $4.78 in pre-market trading.</li>
</ul>
Now Read This: 
<ul class="wp-block-list">
<li><a href="https://www.benzinga.com/cannabis/25/05/45692676/wall-streets-most-accurate-analysts-spotlight-on-3-utilities-stocks-delivering-high-dividend-yields-8">Wall Street&#8217;s Most Accurate Analysts Spotlight On 3 Utilities Stocks Delivering High-Dividend Yields</a> </li>
</ul>
Photo via Shutterstock

ASTL

BMGL

BNAI

BNTX

BSII

CLEU

FAAS

LOGC

LUCD

RSLS

SBET

SLXN

TIRX

Why Blueprint Medicines Shares Are Trading Higher By 27%; Here Are 20 Stocks Moving Premarket

UPDATE: President Donald Trump Says He Would Be Increasing Tariffs On Steel To 50% From 25%; Tariffs To Go Into Effect Next Week

<a href="https://www.bloomberg.com/news/articles/2025-05-30/trump-to-raise-steel-tariffs-to-50-to-help-nippon-us-steel-deal?embedded-checkout=true" title="https://www.bloomberg.com/news/articles/2025-05-30/trump-to-raise-steel-tariffs-to-50-to-help-nippon-us-steel-deal?embedded-checkout=true">https://www.bloomberg.com/news/articles/2025-05-30/trump-to-raise-steel-tariffs-to-50-to-help-nippon-us-steel-deal?embedded-checkout=true</a>

General

'Trump to Raise Steel Tariffs to 50% to Help Nippon-US Steel Deal'- Bloomberg

The most oversold stocks in the materials sector presents an opportunity to buy into undervalued companies.
The RSI is a momentum indicator, which compares a stock&#8217;s strength on days when prices go up to its strength on days when prices go down. When compared to a stock&#8217;s price action, it can give traders a better sense of how a stock may perform in the short term. An asset is typically considered oversold when the <a href="https://www.benzinga.com/topic/rsi">RSI is below 30</a>, according to <a href="https://pro.benzinga.com/">Benzinga Pro</a>.
Here's the latest list of major oversold players in this sector, having an RSI near or below 30.
<h3 class="wp-block-heading">Bolt Projects Holdings Inc (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/BSLK#NASDAQ">BSLK</a>)</h3>
<ul class="wp-block-list">
<li>On May 12, Bolt Projects Holdings posted first-quarter loss of $3.00 per share, versus a year-ago loss of $28.22 per share. &#8220;We saw strong repeat order volume from existing customers coupled with continued growth in our sales pipeline. This combination will aid us in achieving our goal of becoming free cash flow positive,&#8221; said Dan Widmaier, Bolt Projects Chairman and CEO. The company's stock fell around 69% over the past month and has a 52-week low of $1.75.</li>
<li>RSI Value: 24.4</li>
<li>BSLK Price Action: Shares of Bolt Projects fell 19.9% to close at $1.81 on Thursday.</li>
<li>Edge Stock Ratings: Value at 25.12. </li>
</ul>
<figure class="wp-block-image size-full is-resized"><a href="https://www.benzinga.com/quote/BSLK"><img loading="lazy" decoding="async" width="503" height="175" src="https://editorial-assets.benzinga.com/wp-content/uploads/2025/05/29232409/image-401.png" alt="" class="wp-image-932479" style="width:365px;height:auto" srcset="https://editorial-assets.benzinga.com/wp-content/uploads/2025/05/29232409/image-401.png 503w,https://editorial-assets.benzinga.com/wp-content/uploads/2025/05/29232409/image-401-300x104.png 300w" sizes="(max-width: 503px) 100vw, 503px" /></a></figure>
<h3 class="wp-block-heading">Cleveland-Cliffs Inc (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/CLF#NYSE">CLF</a>)</h3>
<ul class="wp-block-list">
<li>On May 29, Jefferies analyst Christopher LeFemina downgraded Cleveland-Cliffs from Buy to Hold and lowered the price target from $10 to $6. The company's stock fell around 28% over the past month and <a href="https://www.benzinga.com/quote/CLF">has a 52-week low</a> of $5.77.</li>
<li>RSI Value: 28.7</li>
<li>CLF Price Action: Shares of Cleveland-Cliffs fell 0.7% to close at $5.90 on Thursday.</li>
<li>Benzinga Pro&#8217;s charting tool helped identify the trend in <a href="https://www.benzinga.com/pro/register?utm_adType=bzprocontent&amp;utm_campaign=14daytrial&amp;utm_ad=0530">CLF stock</a>. </li>
</ul>
<figure class="wp-block-image size-full is-resized"><a href="https://www.benzinga.com/pro/register?utm_adType=bzprocontent&amp;utm_campaign=14daytrial&amp;utm_ad=0530"><img loading="lazy" decoding="async" width="927" height="842" src="https://editorial-assets.benzinga.com/wp-content/uploads/2025/05/29232528/image-402.png" alt="" class="wp-image-932480" style="width:654px;height:auto" srcset="https://editorial-assets.benzinga.com/wp-content/uploads/2025/05/29232528/image-402.png 927w,https://editorial-assets.benzinga.com/wp-content/uploads/2025/05/29232528/image-402-300x272.png 300w,https://editorial-assets.benzinga.com/wp-content/uploads/2025/05/29232528/image-402-768x698.png 768w" sizes="(max-width: 927px) 100vw, 927px" /></a></figure>
<h3 class="wp-block-heading">Inno Holdings Inc (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/INHD#NASDAQ">INHD</a>)</h3>
<ul class="wp-block-list">
<li>On May 12, INNO HOLDINGS announced a strategic cooperation with New Life Technology Development on developing a B2B marketplace platform. Mr. Wei Ding, CEO of INNO, said, &#8220;We are pleased to enter into this collaboration with New Life Tech on development of the B2B marketplace platform. This marks a significant milestone in our commitment to innovative partnerships.&#8221; The company's stock fell around 83% over the past month and has a 52-week <a href="https://www.benzinga.com/quote/INHD">low of $1.11.</a></li>
<li>RSI Value: 27.7</li>
<li>INHD Ltd Price Action: Shares of Inno dipped 5.1% to close at $1.11 on Thursday.</li>
<li>Benzinga Pro&#8217;s signals feature notified of a potential breakout in <a href="https://www.benzinga.com/pro/register?utm_adType=bzprocontent&amp;utm_campaign=14daytrial&amp;utm_ad=0530">INHD shares</a>. </li>
</ul>
<figure class="wp-block-image size-full is-resized"><a href="https://www.benzinga.com/pro/register?utm_adType=bzprocontent&amp;utm_campaign=14daytrial&amp;utm_ad=0530"><img loading="lazy" decoding="async" width="883" height="865" src="https://editorial-assets.benzinga.com/wp-content/uploads/2025/05/29232635/image-403.png" alt="" class="wp-image-932482" style="width:695px;height:auto" srcset="https://editorial-assets.benzinga.com/wp-content/uploads/2025/05/29232635/image-403.png 883w,https://editorial-assets.benzinga.com/wp-content/uploads/2025/05/29232635/image-403-300x294.png 300w,https://editorial-assets.benzinga.com/wp-content/uploads/2025/05/29232635/image-403-768x752.png 768w" sizes="(max-width: 883px) 100vw, 883px" /></a></figure>
Learn more about BZ Edge Rankings—click to see scores for other stocks in the sector and s<a href="https://www.benzinga.com/premium/ideas/benzinga-edge-2#:~:text=Turn%20Market%20Chaos,when%20markets%20rebound">ee how they compare.</a>
Read This Next: 
<ul class="wp-block-list">
<li><a href="https://www.benzinga.com/25/05/45667868/top-2-materials-stocks-that-are-ticking-portfolio-bombs">Top 2 Materials Stocks That Are Ticking Portfolio Bombs</a> </li>
</ul>
Photo via Shutterstock

Pre-Market Outlook

INHD

Top 3 Materials Stocks That Could Blast Off This Month

Jefferies analyst Christopher LeFemina downgrades Cleveland-Cliffs (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/CLF#NYSE">CLF</a>) from Buy to Hold and lowers the price target from $10 to $6.

Downgrades

Price Target

Analyst Ratings

Jefferies Downgrades Cleveland-Cliffs to Hold, Lowers Price Target to $6

Throughout the last three months, 5 analysts have evaluated Cleveland-Cliffs (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/CLF#NYSE">CLF</a>), offering a diverse set of opinions from bullish to bearish.
The table below offers a condensed view of their recent ratings, showcasing the changing sentiments over the past 30 days and comparing them to the preceding months.
<table>
<thead>
<tr>
<th></th>
<th align="right">Bullish</th>
<th align="right">Somewhat Bullish</th>
<th align="right">Indifferent</th>
<th align="right">Somewhat Bearish</th>
<th align="right">Bearish</th>
</tr>
</thead>
<tbody>
<tr>
<td>Total Ratings</td>
<td align="right">4</td>
<td align="right">0</td>
<td align="right">0</td>
<td align="right">0</td>
<td align="right">1</td>
</tr>
<tr>
<td>Last 30D</td>
<td align="right">0</td>
<td align="right">0</td>
<td align="right">0</td>
<td align="right">0</td>
<td align="right">1</td>
</tr>
<tr>
<td>1M Ago</td>
<td align="right">1</td>
<td align="right">0</td>
<td align="right">0</td>
<td align="right">0</td>
<td align="right">0</td>
</tr>
<tr>
<td>2M Ago</td>
<td align="right">1</td>
<td align="right">0</td>
<td align="right">0</td>
<td align="right">0</td>
<td align="right">0</td>
</tr>
<tr>
<td>3M Ago</td>
<td align="right">2</td>
<td align="right">0</td>
<td align="right">0</td>
<td align="right">0</td>
<td align="right">0</td>
</tr>
</tbody>
</table>
Insights from analysts' 12-month price targets are revealed, presenting an average target of $11.63, a high estimate of $17.00, and a low estimate of $3.91. Highlighting a 13.72% decrease, the current average has fallen from the previous average price target of $13.48. 
<img src="https://www.benzinga.com/files/images/story/2025/1748440925_0.png" alt="price target chart" />
<h2>Diving into Analyst Ratings: An In-Depth Exploration</h2>
A clear picture of Cleveland-Cliffs's perception among financial experts is painted with a thorough analysis of recent analyst actions. The summary below outlines key analysts, their recent evaluations, and adjustments to ratings and price targets.
<table>
<thead>
<tr>
<th>Analyst</th>
<th>Analyst Firm</th>
<th>Action Taken</th>
<th>Rating</th>
<th>Current Price Target</th>
<th>Prior Price Target</th>
</tr>
</thead>
<tbody>
<tr>
<td>Gordon Johnson</td>
<td>GLJ Research</td>
<td>Maintains</td>
<td>Sell</td>
<td>$3.91</td>
<td>$3.91</td>
</tr>
<tr>
<td>Mike Harris</td>
<td>Goldman Sachs</td>
<td>Lowers</td>
<td>Buy</td>
<td>$11.25</td>
<td>$13.00</td>
</tr>
<tr>
<td>Nick Giles</td>
<td>B. Riley Securities</td>
<td>Lowers</td>
<td>Buy</td>
<td>$17.00</td>
<td>$20.00</td>
</tr>
<tr>
<td>Martin Englert</td>
<td>Seaport Global</td>
<td>Lowers</td>
<td>Buy</td>
<td>$11.00</td>
<td>$13.50</td>
</tr>
<tr>
<td>Mike Harris</td>
<td>Goldman Sachs</td>
<td>Lowers</td>
<td>Buy</td>
<td>$15.00</td>
<td>$17.00</td>
</tr>
</tbody>
</table>
<h3>Key Insights:</h3>
<ul>
<li>Action Taken: Analysts adapt their recommendations to changing market conditions and company performance. Whether they 'Maintain', 'Raise' or 'Lower' their stance, it reflects their response to recent developments related to Cleveland-Cliffs. This information provides a snapshot of how analysts perceive the current state of the company.</li>
<li>Rating: Gaining insights, analysts provide qualitative assessments, ranging from 'Outperform' to 'Underperform'. These ratings reflect expectations for the relative performance of Cleveland-Cliffs compared to the broader market.</li>
<li>Price Targets: Understanding forecasts, analysts offer estimates for Cleveland-Cliffs's future value. Examining the current and prior targets provides insight into analysts' changing expectations.</li>
</ul>
Understanding these analyst evaluations alongside key financial indicators can offer valuable insights into Cleveland-Cliffs's market standing. Stay informed and make well-considered decisions with our Ratings Table.
<a href="https://www.benzinga.com/quote/CLF/analyst-ratings?adType=benzinga-insights&amp;ad=analyst-ratings&amp;campaign=wallstreetadvantage">Stay up to date on Cleveland-Cliffs analyst ratings.</a>
<h2>All You Need to Know About Cleveland-Cliffs</h2>
Cleveland-Cliffs Inc is a flat-rolled steel producer and manufacturer of iron ore pellets in North America. It is organized into four operating segments based on differentiated products, Steelmaking, Tubular, Tooling and Stamping and European Operations, but operates through one reportable segment -Steelmaking. It is vertically integrated from mined raw materials, direct reduced iron, and ferrous scrap to primary steelmaking and downstream finishing, stamping, tooling and tubing. It serves a diverse range of other markets due to its comprehensive offering of flat-rolled steel products. Geographically, it operates in the United States, Canada and other countries. The majority of revenue is from the United States. It is a supplier of steel to the automotive industry in North America.
<h3>Cleveland-Cliffs: A Financial Overview</h3>
Market Capitalization Analysis: Below industry benchmarks, the company's market capitalization reflects a smaller scale relative to peers. This could be attributed to factors such as growth expectations or operational capacity.
Negative Revenue Trend: Examining Cleveland-Cliffs's financials over 3M reveals challenges. As of 31 March, 2025, the company experienced a decline of approximately -10.96% in revenue growth, reflecting a decrease in top-line earnings. When compared to others in the Materials sector, the company faces challenges, achieving a growth rate lower than the average among peers.
Net Margin: The company's net margin is below industry benchmarks, signaling potential difficulties in achieving strong profitability. With a net margin of -10.69%, the company may need to address challenges in effective cost control.
Return on Equity (ROE): Cleveland-Cliffs's ROE lags behind industry averages, suggesting challenges in maximizing returns on equity capital. With an ROE of -7.66%, the company may face hurdles in achieving optimal financial performance.
Return on Assets (ROA): Cleveland-Cliffs's ROA is below industry standards, pointing towards difficulties in efficiently utilizing assets. With an ROA of -2.37%, the company may encounter challenges in delivering satisfactory returns from its assets.
Debt Management: With a high debt-to-equity ratio of 1.22, Cleveland-Cliffs faces challenges in effectively managing its debt levels, indicating potential financial strain.
<h2>Understanding the Relevance of Analyst Ratings</h2>
Benzinga tracks 150 analyst firms and reports on their stock expectations. Analysts typically arrive at their conclusions by predicting how much money a company will make in the future, usually the upcoming five years, and how risky or predictable that company's revenue streams are.
Analysts attend company conference calls and meetings, research company financial statements, and communicate with insiders to publish their ratings on stocks. Analysts typically rate each stock once per quarter or whenever the company has a major update.
Some analysts publish their predictions for metrics such as growth estimates, earnings, and revenue to provide additional guidance with their ratings. When using analyst ratings, it is important to keep in mind that stock and sector analysts are also human and are only offering their opinions to investors.
If you want to keep track of which analysts are outperforming others, you can view updated analyst ratings along withanalyst success scores in <a href="https://www.benzinga.com/pro/">Benzinga Pro</a>.
Breaking: Wall Street's Next Big Mover
Benzinga's #1 analyst just identified a stock poised for explosive growth. This under-the-radar company could surge 200%+ as major market shifts unfold. <a href="https://www.benzinga.com/premium/ideas/turning-point-trader-checkout-2/?t=Tu1tu3arja3be22tu36&amp;adType=benzinga-insights&amp;ad=analyst-ratings&amp;campaign=wallstreetadvantag">Click here for urgent details</a>.
This article was generated by Benzinga's automated content engine and reviewed by an editor.

Where Cleveland-Cliffs Stands With Analysts

GLJ Research analyst Gordon Johnson downgrades Cleveland-Cliffs (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/CLF#NYSE">CLF</a>) from Buy to Sell and maintains the price target from $3.91 to $3.91.

GLJ Research Downgrades Cleveland-Cliffs to Sell, Maintains Price Target to $3.91

Live On CNBC, Jim Lebenthal Defends Cleaveland-Cliffs Stake; Shares See A Pop In Volume To The Upside

It took one sentence from <a href="https://www.benzinga.com/topic/donald-trump">President Donald Trump</a> to jolt United States Steel Corp (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/X#NYSE">X</a>) out of a 20-year barrier. 
"This 20yr base in US Steel just needed a little Trump pump," <a href="https://x.com/sstrazza/status/1927128103790211315">posted</a> All Star Charts strategist Steven Strazza on X, capturing the chart-watching community's excitement. 
<figure class="wp-block-embed is-type-rich is-provider-twitter wp-block-embed-twitter"> 
<div class="wp-block-embed__wrapper">
<blockquote class="twitter-tweet" data-width="500" data-dnt="true">This 20yr base in US Steel just needed a little Trump pump. I think it goes a lot higher from here. <a href="https://twitter.com/search?q=%24X&amp;src=ctag&amp;ref_src=twsrc%5Etfw">$X</a> <a href="https://t.co/h0OhLCH4vr">pic.twitter.com/h0OhLCH4vr</a>
&mdash; Steven Strazza (@sstrazza) <a href="https://twitter.com/sstrazza/status/1927128103790211315?ref_src=twsrc%5Etfw">May 26, 2025</a></blockquote>
<script async src="https://platform.twitter.com/widgets.js" charset="utf-8"></script></div>
</figure>
<h2 class="wp-block-heading">Trump's Pitch Sparks A Chart-Breaking Rally</h2>
The stock surged more than 21% after the president announced a "planned partnership" between U.S. Steel and Japan's Nippon Steel, pledging the company would stay American, headquartered in Pittsburgh, and promising 70,000 jobs and $14 billion in U.S. investment.
Related: <a href="https://www.benzinga.com/25/05/45596866/president-trump-approves-us-steel-nippon-steel-partnership">President Trump Approves US Steel, Nippon Steel Partnership</a>
<figure class="wp-block-image size-full"><a href="https://www.benzinga.com/pro/register?utm_adType=bzprocontent&amp;utm_campaign=14daytrial&amp;utm_ad=0527"><img loading="lazy" decoding="async" width="631" height="486" src="https://editorial-assets.benzinga.com/wp-content/uploads/2025/05/27061647/Screenshot-2025-05-27-at-3.46.35-PM.png" alt="" class="wp-image-928108" srcset="https://editorial-assets.benzinga.com/wp-content/uploads/2025/05/27061647/Screenshot-2025-05-27-at-3.46.35-PM.png 631w,https://editorial-assets.benzinga.com/wp-content/uploads/2025/05/27061647/Screenshot-2025-05-27-at-3.46.35-PM-300x231.png 300w" sizes="(max-width: 631px) 100vw, 631px" /></a></figure>
<a href="https://www.benzinga.com/pro/register?utm_adType=bzprocontent&amp;utm_campaign=14daytrial&amp;utm_ad=0527">Chart created using Benzinga Pro</a>
Technically, the breakout is hard to miss. U.S. Steel stock is trading far above its eight, 20, 50, and 200-day simple moving averages (SMAs), with the eight-day average sitting at $42.87 and the stock now at $52.01. 
The RSI (relative strength index) of 76.02 suggests the stock is overbought, while the MACD (moving average convergence/divergence indicator) reading of 0.85 points to bullish momentum. 
Traders are seeing textbook confirmation of a bullish breakout.
<h2 class="wp-block-heading">Analyst Skepticism Clouds Deal Optimism</h2>
But not everyone is convinced the rally is built on solid footing. JPMorgan analyst Bill Peterson maintained a "Neutral" stance, stating "questions remain" over the deal's structure and execution. 
While some media outlets have reported that Trump approved Nippon Steel's acquisition, subsequent statements from the president painted a murkier picture. He&#8217;s described the deal as an "investment" or "partial ownership" rather than a full takeover. "It will be controlled by the United States. Otherwise, I wouldn't make the deal," Trump said.
Peterson noted that the newly announced $14 billion investment figure is far above the previously suggested $2.7 billion, raising questions about how—and whether—that capital would be deployed in just over a year. Nippon Steel's Vice Chairman reiterated the company's intent for a full buyout as recently as May 20, saying there would be "no free technology" in a joint venture structure.
<h2 class="wp-block-heading">Steel Rivals Sink As U.S. Steel Soars</h2>
Market reaction among peers painted a telling picture: while U.S. Steel soared, rivals like Nucor Corp (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/NUE#NYSE">NUE</a>), Steel Dynamics Inc (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/STLD#NASDAQ">STLD</a>) and Cleveland-Cliffs Inc (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/CLF#NYSE">CLF</a>) declined &#8211; suggesting the market expects a more competitive steel landscape if the deal materializes.
For now, U.S. Steel bulls are riding the momentum, but whether this Trump-fueled breakout has structural legs will depend on how the fog around the deal clears—or doesn't—in the days ahead.
Read Next: 
<ul class="wp-block-list">
<li><a href="https://www.benzinga.com/25/05/45615292/this-united-states-steel-analyst-is-no-longer-bullish-here-are-top-3-downgrades-for-tuesday">This United States Steel Analyst Is No Longer Bullish; Here Are Top 3 Downgrades For Tuesday</a></li>
</ul>
Photo: Shutterstock

Technicals

US Steel Stock Smashes 20-Year Barrier On 'Trump Pump,' Yet Questions Remain

CSTM

SCCO

TECK

Shares of metals stocks are trading higher amid overall market strength after the US and China agreed to a temporary reduction in most tariffs on each other's goods. A decrease of trade tensions could reduce demand uncertainty for base metals.

Goldman Sachs analyst Mike Harris maintains Cleveland-Cliffs (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/CLF#NYSE">CLF</a>) with a Buy and lowers the price target from $13 to $11.25.

Goldman Sachs Maintains Buy on Cleveland-Cliffs, Lowers Price Target to $11.25

Benzinga examined the prospects for <a href="http://www.benzinga.com/trading-ideas" target="_blank" rel="noreferrer noopener">many investors' favorite stocks</a> over the last week — here's a look at some of our top stories.
U.S. markets experienced a notable upswing this week, driven by President Donald Trump's announcement of a trade agreement with the United Kingdom. The deal includes reductions in tariffs on UK automobiles, steel, and aluminum, and grants the UK access to the U.S. beef market. This development spurred optimism for potential future trade agreements and contributed to a rally in equities, with the S&amp;P 500 and Nasdaq posting gains. Additionally, Bitcoin (CRYPTO: <a class="ticker" href="https://www.benzinga.com/quote/btc/usd">BTC</a>) surpassed the $100,000 mark, reflecting increased investor confidence and a shift toward riskier assets.
Despite the positive market response, concerns about the broader economic outlook persist. The Federal Reserve opted to maintain current interest rates, citing uncertainties related to the new tariff policies and their potential impact on inflation and employment. Analysts warn of the risk of stagflation — a combination of stagnant economic growth and high inflation—especially as the effects of the tariffs become more pronounced.
Looking ahead, high-level trade discussions between U.S. and Chinese officials are scheduled, aiming to address ongoing tensions and possibly adjust existing tariffs. Investors are closely monitoring these developments, as outcomes could significantly influence market dynamics and economic forecasts in the coming months.
Benzinga provides daily reports on the stocks most popular with investors. Here are a few of this past week's most bullish and bearish posts that are worth another look.

The Bulls
<a href="https://www.benzinga.com/25/05/45259042/ibm-thinks-big-ai-delivers-bigger-why-bulls-are-charging-toward-300">"IBM Thinks Big, AI Delivers Bigger – Why Bulls Are Charging Toward $300"</a>, by Surbhi Jain, reports that International Business Machines Corp. (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/IBM#NYSE">IBM</a>) shares have climbed 48% over the past year and 13% year-to-date, driven by strong technical indicators and a bullish AI strategy, prompting Wedbush analyst Dan Ives to reiterate an Outperform rating with a $300 price target.
<a href="https://www.benzinga.com/25/05/45295534/novavax-reports-q1-profit-as-revenue-surges-to-over-600-million-and-lower-costs-raises-2025-forecasts">"Novavax reports Q1 profit as revenue surges to over $600 million and lower costs, raises 2025 forecasts"</a>, by Vandana Singh, reports that Novavax Inc. (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/NVAX#NASDAQ">NVAX</a>) posted a Q1 profit of $2.93 per share on $667 million in revenue — driven by $603 million from terminated advance purchase agreements — while raising its 2025 revenue forecast to $975 million-$1.025 billion and noting ongoing discussions with the FDA for full approval of its COVID-19 vaccine.
<a href="https://www.benzinga.com/25/05/45297555/hims-hers-stocks-100-surge-is-squeezing-shorts-and-it-might-just-be-getting-started">"Hims &amp; Hers stock's 100% surge is squeezing shorts—and it might just be getting started"</a>, by Surbhi Jain, reports that Hims &amp; Hers Health Inc. (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/HIMS#NYSE">HIMS</a>) shares have doubled over the past month, fueled by strong Q1 earnings, a partnership with Novo Nordisk to offer Wegovy, and a high short interest of 33% of float, suggesting a classic short squeeze may be underway.
For additional bullish calls of the past week, check out the following:
<a href="https://www.benzinga.com/government/regulations/25/05/45298562/chipmakers-enter-bullish-seasonal-window-5-stocks-that-could-outperform">Chipmakers Enter Bullish Seasonal Window: 5 Stocks That Could Outperform</a>
<a href="https://www.benzinga.com/25/05/45291509/nvidia-broadcom-amd-surge-as-trump-reshapes-ai-chip-export-rules-to-ease-market-pressure">Nvidia, Broadcom, AMD Gain As Trump Reshapes AI Chip Export Rules To Ease Market Pressure</a>
<a href="https://www.benzinga.com/news/earnings/25/05/45268589/sunrun-stock-rallies-after-strong-q1-report-details">Sunrun Stock Rallies After Strong Q1 Report: Details</a>

The Bears
<a href="https://www.benzinga.com/news/earnings/25/05/45268429/arm-holdings-stock-plunges-after-q4-results-heres-why">"Arm Holdings Stock Plunges After Q4 Results: Here's Why"</a>, by Erica Kollmann, reports that Arm Holdings plc (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/ARM#NASDAQ">ARM</a>) shares fell nearly 9% after the company beat Q4 expectations with $1.24 billion in revenue and $0.55 EPS but issued weaker-than-expected guidance for fiscal 2026, citing uncertainty in licensing deals and global trade tensions.
<a href="https://www.benzinga.com/25/05/45272331/super-micro-slides-as-ai-server-delays-nvidia-supply-limits-weigh-on-analyst-ratings">"Super Micro slides as AI server delays, Nvidia supply limits weigh on analyst ratings"</a>, by Anusuya Lahiri, reports that Super Micro Computer Inc. (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/SMCI#NASDAQ">SMCI</a>) shares fell 5% after the company missed Q3 revenue and EPS expectations and issued a cautious Q4 outlook, attributing delays to customers awaiting NVIDIA Corp. (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/NVDA#NASDAQ">NVDA</a>) Blackwell GPUs and facing supply constraints, leading analysts to lower forecasts amid concerns over AI server demand and margin pressures.
<a href="https://www.benzinga.com/25/05/45261806/sarepta-therapeutics-stock-sinks-on-gloomy-forecast-analysts-cut-price-forecasts">"Sarepta Therapeutics stock sinks on gloomy forecast, analysts cut price forecasts"</a>, by Vandana Singh, reports that Sarepta Therapeutics Inc. (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/SRPT#NASDAQ">SRPT</a>) shares fell after the company posted a deeper-than-expected Q1 loss and cut its 2025 forecast due to Elevidys rollout delays, despite beating revenue estimates.
For more bearish takes, be sure to see these posts:
<a href="https://www.benzinga.com/news/earnings/25/05/45239188/arista-networks-shares-fall-after-mixed-q1-results-eps-beat-revenues-miss-q2-guidance-below-estimates">Arista Networks Shares Fall After Mixed Q1 Results: EPS Beat, Revenues Miss, Q2 Guidance Below Estimates</a>
<a href="https://www.benzinga.com/news/earnings/25/05/45270996/cleveland-cliffs-stock-falls-on-q1-earnings-miss-steelmaker-idles-6-facilities-taking-decisive-action-to-streamline-our-operations">Cleveland-Cliffs Stock Falls On Q1 Earnings Miss, Steelmaker Idles 6 Facilities: ‘Taking Decisive Action To Streamline Our Operations'</a>
<a href="https://www.benzinga.com/news/earnings/25/05/45302422/coinbase-q1-earnings-highlights-revenue-eps-miss-2025">Coinbase Slips On Q1 Miss, Highlights SEC ‘Win' And Strategic Bitcoin Reserve Executive Order</a>

Keep up with all the latest breaking news and trading ideas by following <a href="https://twitter.com/Benzinga" target="_blank" rel="noreferrer noopener">Benzinga</a><a href="http://twitter.com/Benzinga" target="_blank" rel="noreferrer noopener"> on X</a>.
Image created using artificial intelligence via Midjourney.

$BTC

AMAT

ANET

AVGO

COIN

Hims & Hers Health, Inc. Class A Common Stock

HIMS

MRVL

MSFT

NVAX

ORCL

SMCI

iShares PHLX SOX Semiconductor Sector Index Fund

SOXX

SRPT

Benzinga Bulls And Bears: IBM, Novavax, Arm Holdings — And UK Trade Deal Boosts Markets

Legal

Press Releases

Kirby McInerney LLP Announces Investigation of Claims Against Cleveland-Cliffs Inc. (CLF) on Behalf of Investors

INVESTOR ALERT: Pomerantz Law Firm Investigates Claims On Behalf of Investors of Cleveland-Cliffs Inc. - CLF

Securities Fraud Investigation Into Cleveland-Cliffs Inc. (CLF) Announced – Investors Who Lost Money Urged To Contact The Law Offices of Frank R. Cruz

CLEVELAND-CLIFFS ALERT: Bragar Eagel & Squire, P.C. is Investigating Cleveland-Cliffs Inc. on Behalf of Cleveland-Cliffs Stockholders and Encourages Investors to Contact the Firm

Cleveland-Cliffs Inc. (CLF) Investors Who Lost Money – Contact Law Offices of Howard G. Smith About Securities Fraud Investigation

Securities Fraud Investigation Into Cleveland-Cliffs Inc. (CLF) Announced – Investors Who Lost Money Urged To Contact Glancy Prongay & Murray LLP, a Leading Securities Fraud Law Firm

CLF Investors Have Opportunity to Join Cleveland-Cliffs Inc. Fraud Investigation with the Schall Law Firm

Bragar Eagel & Squire, P.C. Is Investigating Kohl's and Cleveland-Cliffs and Encourages Investors to Contact the Firm

Kirby McInerney LLP is Investigating Potential Shareholder Claims Against Cleveland-Cliff Inc. (CLF)

Bragar Eagel & Squire, P.C. Is Investigating TechTarget, SelectQuote, GoHealth, and Cleveland-Cliffs and Encourages Investors to Contact the Firm

GOCO

SLQT

TTGT

Ascent Industries

Alpha Metallurgical Resources, Inc. Common Stock

Alpha Metallurgical

Commercial Metals

Carpenter Technology Corporation Common Stock

Carpenter Tech

Friedman Indus

Gerdau

Warrior Met Coal

Ramaco Resources, Inc. - Class A Common Stock

Ramaco Resources

Ramaco Resources, Inc. - Class B Common Stock

Mesabi Tr

ArcelorMittal

Metallus

Nucor

POSCO HOLDINGS INC. American Depositary Shares (Each representing 1/4th of a share of Common Stock)

POSCO Holdings

Radius Recycling, Inc. - Class A Common Stock

Radius Recycling

Reliance

Ryerson Holding

Companhia Siderurgica Nacional S.A. Common Stock

Companhia Siderurgica

Steel Dynamics

SunCoke Energy

Ternium S.A. Ternium S.A. American Depositary Shares (each representing ten shares, USD1.00 par value)

Comments

Cleveland-Cliffs

Unusual Options Activity for

Notizie

PARTENAIRE / CONTRIBUTEUR

BENZINGA MONDIAL